Chinese medicine improves spinal injury in rats
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2013
Singapore: A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-...Read more
Eisai, UCL form neuro R&D alliance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Dec, 2012
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...Read more
Novartis has a substantial drug pipeline for all diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2012
Singapore: Novartis planning to leverage on its R&D pipeline to taste commercial success through 2017. Continuing R&...Read more
Taiwan research centre to develop dengue vaccine with Janssen
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2015
Singapore: BRIM Biotechnology has collaborated with Janssen Pharmaceutica to pursue research, development and commercial...Read more
Phylogica looks for tie-ups in Asia: COO Nick Woolf
Drug Discovery | Influencers | By BioSpectrum Bureau | 3 Comment | 15 May, 2012
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...Read more
Ono ties up with BioFocus for drug research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...Read more
FDA end-of-phase II for head lice product
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 06 Sep, 2012
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...Read more
Millennium announces positive results of orteronel study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...Read more
3SBio, Selecta join hands to develop gout therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014
Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...Read more
Patrys begins multiple myeloma trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...Read more
GVK, Onconova to develop cancer drugs
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Singapore: GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for c...Read more
Myeloma Network raises cancer awareness
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2013
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the ...Read more
Novo Nordisk announces trial data of NovoMix 30
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2012
Bangalore: New data from a subgroup analysis of the A1chieve study showed that intensifying treatment with NovoMix 30 (B...Read more
Boehringer starts phase III leukaemia study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2013
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and pot...Read more
Takeda resubmits NDA to the US FDA for alogliptin
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 30 Jul, 2012
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...Read more
Phylogica achieves research milestone
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...Read more
Gilead's angina drug shows +ve result in diabetics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Mar, 2013
Singapore: Gilead Sciences has successfully progressed phase IV Terisa (Type 2 Diabetes Evaluation of Ranolazine in subj...Read more
AstraZeneca to integrate dendrimer drug delivery technology in oncology portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2014
Singapore: Global Pharmaceutical company, AstraZeneca plans to integrate Dendrimer drug delivery technology developed by...Read more